Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. April 2025 06:30 ET | Quelle: Merakris Therapeutics

Merakris Therapeutics Appoints Roger Ilagan to Chief Scientific Officer

RESEARCH TRIANGLE PARK, N.C., April 10, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics has named Roger Ilagan, PhD as its new Chief Scientific Officer (CSO). Responsible for guiding the biologic...
09. Februar 2018 11:03 ET | Quelle: American College of Rheumatology

American College of Rheumatology Praises Congressional Leaders for Passing Spending Bill that Includes Part B Fix, Therapy Caps Repeal

Washington, DC, Feb. 09, 2018 (GLOBE NEWSWIRE) -- The American College of Rheumatology praises Congressional leaders for passing today’s sweeping spending agreement, which includes a technical...
10. August 2017 05:00 ET | Quelle: BCC Research

Market for Antibody Drug Conjugates to Reach $4.2B by 2021

WELLESLEY, Mass., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Technological advancements, the rising incidence of cancer, and an increasing demand for biologic therapies are driving the market for...